ArticleCancer research communications2023

Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins.

Junkai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.